Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 3.88 as of 2026-10-06T20:36:39.339Z.
Calculation as of: 2026-10-06T20:36:39.339Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
3.88
SECTOR MEDIAN · HEALTHCARE
2.39
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
+62.34%
vs the sector median at left
Market Cap
$1.74B
PB Ratio
N/A
TTM Avg
90.35
3Y Avg
69.93
5Y Avg
29.82
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.77B | 3.88 | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.05 | 1.15 | 1.54 | 2.12 |
| Novocure Ltd (NVCR)vs › | $1.74B | 5.16 | 4.80 | 5.01 | 9.97 |
| Absci Corporation (ABSI)vs › | $1.74B | 7.07 | 4.16 | 2.63 | 2.00 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | N/A | 90.35 | 69.93 | 29.82 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 6.55 | 20.53 | 18.19 | 13.71 |
| Xencor, Inc. (XNCR)vs › | $1.81B | 3.59 | 2.10 | 1.83 | 2.09 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 4.30 | 5.58 | 5.58 | 5.07 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 2.38 | 2.19 | 1.95 | 3.16 |
| Azenta, Inc. (AZTA)vs › | $1.81B | 1.20 | 0.82 | 1.06 | 1.61 |
P/B Ratio
3.88
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
